Chief Physician, M.D., Ph.D., Master's Supervisor Specializes in comprehensive surgical management of benign and malignant pancreatic and biliary diseases, conversion therapy for locally advanced and metastatic pancreatic cancer, and treatment of chronic pancreatitis. Completed a six-month visiting fellowship at Johns Hopkins University School of Medicine, USA. Research Achievements Published over 40 SCI papers in renowned international journals including Gastroenterology, GUT, Cancer Research, Clinical Cancer Research, and British Journal of Cancer. Led and undertook more than ten research projects at various levels, including those funded by the National Natural Science Foundation of China, Shanghai Municipal Health Commission, Shanghai Science and Technology Commission, and Shanghai Jiao Tong University. Received the "Shanghai Science and Technology Progress Award, Third Prize." Research Directions Long-term engagement in clinical treatment and basic research of pancreatic malignancies. Admits a large number of patients with pancreatic and biliary tract malignancies annually and conducts multiple clinical studies related to pancreatic malignancies. For patients with locally advanced pancreatic cancer, successfully secures surgical opportunities for some patients through comprehensive treatment strategies centered on neoadjuvant therapy, significantly prolonging survival time for these patients. For pancreatic cancer patients with liver metastases, based on the successful prolongation of survival through comprehensive treatment, proposes the concept of simultaneous surgery for patients with oligometastatic liver disease, creating new hope for surgical resection in patients with advanced metastatic pancreatic cancer.